Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer (Q34527500)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer
scientific article

    Statements

    Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer (English)
    Philipp Kiewe
    Stephan Hasmüller
    Steffen Kahlert
    Maja Heinrigs
    Brigitte Rack
    Alexander Marmé
    Michael Jäger
    Horst Lindhofer
    3085-3091

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit